Lucio Marinelli

Associate professor in Neurology. Fond of my son and daughter. Free open source software amateur programmer and piano player.

[Exploration of Neuroprotective Therapy @ExplorNeuroprot]

📢NEW Article Out!
🖊️Last publication from Prof. Lucio Marinelli @Marinelli_Lucio

📊A questionnaire-based study on cranio-cervical-mandibular symptoms in clarinet students
🔗Full research: https://t.co/1H6DcJz4X7

#Pain #TemporomandibularDisorder #TemporomandibularJoint

[Toxins MDPI @Toxins_MDPI]

The recent highly viewed article #mdpitoxins is from Dr. Lucio Marinelli @Marinelli_Lucio et al. entitled "Effectiveness of #Botulinum Toxin on Pain in Stroke Patients Suffering from Upper Limb Spastic Dystonia"
Full article🔗https://t.co/rmrN0Nqx8Q

[Lucio Marinelli @Marinelli_Lucio]

Proud to present my first medical informatics paper:
"Tagging EEG features within exam reports to quickly generate databases for research purposes"

https://t.co/EhVghdqAb7

@flaviovillani

[Exploration of Neuroprotective Therapy @ExplorNeuroprot]

An interesting #video from Prof. @Marinelli_Lucio (University of Genoa, Italy) shares his research on "Emerging #Indications for #Botulinum #Toxin Treatment". I believe you will not want to miss it.
Welcome to view at https://t.co/P9pZyilhEg
You are welcome to spread it to others

[IFCN and its Clinical Neurophysiology journals @ClinicalNeuroph]

[Parkinson's disease (PD)] Marinelli et al.: “A thorough dissection and understanding of the processes involved in motor learning is warranted to provide solid bases for effective medical, surgical and rehabilitative approaches in PD.”

https://t.co/FEhxbnhd1a
#ClinicalNeuroph

[Exploration of Neuroprotective Therapy @ExplorNeuroprot]

With the journal's development, we welcome and encourage capable and motivated experts/researchers to participate in reviewing work as reviewers.
If you are interested, please contact us. We look forward to your participation in the journal's future!
https://t.co/DAXRphStgZ

[IFCN and its Clinical Neurophysiology journals @ClinicalNeuroph]

[European Congress of Clinical Neurophysiology 2023] Abstract submission deadline is Jan 30, 2023. For young investigators, the EMEAC-IFCN bursaries are increased from €300 to €500.

Abstract submission: https://t.co/X9dmyqCIcB

Program: https://t.co/x5tvq4vLtI

#ECCN2023

[Lucio Marinelli @Marinelli_Lucio]

#Twitter ban of third-party apps stopped my TwidereX from working. Since I will not install the official Twitter app, I will access my account only with browsers and much less frequently, thus missing many posts. BTW, I will much more active on #Mastodon ! https://t.co/XGuXBanbcT

[MediciSenzaFrontiere @MSF_ITALIA]

🔴INACCETTABILE il piano israeliano per lo sfollamento forzato di un migliaio di palestinesi da Masafer Yatta #Cisgiordania

Chiediamo alla comunità internazionale di proteggere le persone coinvolte e garantire il rispetto dei loro diritti umani.
https://t.co/hbQqxIBGei

[OpenStreetMap @openstreetmap]

Today we have more than 10 million registered users! Why not join us? Sign up to contribute to the map near you!

[Exploration of Neuroprotective Therapy @ExplorNeuroprot]

New #Special Issue edited by Prof. Ebenezer Olatunde Farombi is launched today!
Topic: #Neuroinvasion, #Neuropathogenesis and #Neuroprotective Agents in the Pathophysiology of #SARS-CoV-2
Submission Deadline: July 31, 2023
Learn more and submit articles at https://t.co/OFOczWZmGp

[Exploration of Neuroprotective Therapy @ExplorNeuroprot]

New #SpecialIssue "Therapeutic Targets for #Neuroprotection in #Ischemic Stroke" edited by Dr. Silvia Fischer just launched!
All #submissions will enjoy #free to publish (no APC). #Deadline: July 31, 2023
Learn more and submit: https://t.co/aMkf62gryI

[IFCN and its Clinical Neurophysiology journals @ClinicalNeuroph]

[European Congress of Clinical Neurophysiology 2023]

Submission deadline: January 23, 2023.
https://t.co/X9dmyqCIcB

We hope to see you at #ECCN2023 in Marseille on May 9-12, 2023.

[Geert Verheyden @KULneuroPT]

T-1 week

[Exploration of Neuroprotective Therapy @ExplorNeuroprot]

A new special issue of "Penetrance and Metabolism of Brain Drugs" edited by Prof. Thomas Efferth was just launched in ENT journal. Welcome to learn more about this novel topical issue at https://t.co/7ERX4M3uWy Authors who submit to this special issue will enjoy free to publish!

[Neurology Today @NeurologyToday]

The @US_FDA has approved the anti-monoclonal antibody medication #lecanemab to treat #Alzheimers: What you should know about it: https://t.co/L99YGpCpex
#neurotwitter #BrainHealth #dementia @AANMember

[IFCN and its Clinical Neurophysiology journals @ClinicalNeuroph]

[Dystonia and Spastic Dystonia] Trompetto et al.: “By definition, dystonia is a movement disorder, whereas spastic dystonia is not.”

https://t.co/GzpZoS5uMR
@UniGenova
#Spasticity #Dystonia #ClinicalNeuroph

[Lucio Marinelli @Marinelli_Lucio]

What did you expect? This is what happens when researchers feel such pressure to publish! Calm, time to read and think is needed, listen #miur

[Itai Yanai @ItaiYanai]

New Nature paper provides evidence that science has become less innovative since the 1950s. The authors suggest reversing the trend by:
1. reading widely,
2. focusing less on quantity of papers, & more on research quality,
3. taking year-long sabbaticals.
https://t.co/oYV5JCXRl8

[Exploration of Neuroprotective Therapy @ExplorNeuroprot]

New Released Article "Biomarkers in small fiber neuropathy" from the Special issue "The Future of Biomarkers in CNS Diseases" edited by Dr. Vijay K Sharma. Welcome to read the full text at https://t.co/QrN7GVepjG
#small fiber neuropathy#biomarkers #antibodies# skin biopsy

[Guy Verhofstadt @guyverhofstadt]

Exactly 50 years after its first entry in the European union, a nearly two thirds majority of citizens in the UK want a new referendum to rejoin !

https://t.co/XQIijq1DaO